At a glance
ClinicalIndex Comparison RecordN/ACompleted· 135 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Randomized Controlled Trial Comparing the Performance of 22 Gauge Versus 25 Gauge EUS-FNA Needles
In Brief
An observational study for Mediastinal Tumours and Lymph Nodes and 4 related conditions. Completed, enrolled 135 participants across 9 sites in 3 countries.
Detailed Summary
The aim of the study is to compare the performance characteristics of EUS-FNA 22 Gauge needle and EUS FNA 25 Gauge needle in terms of cellularity and diagnostic yield for diagnosis of various pathologies, including lymph nodes, pancreatic, luminal and other lesions outlined by EUS.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMediastinal Tumours and Lymph Nodes, Celiac, Perigastric and Peri-pancreatic Lymph Nodes, Pancreatic Masses, Liver Masses, Adrenal Masses
CountriesDenmark, Germany, Romania
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2009
First PostedNov 2009
Primary CompletionApr 2010
Study CompletionDec 2012
TodayJul 2026
First PostedNov 19, 2009
Enrollment StartNov 1, 2009
Primary CompletionApr 1, 2010
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 16.6 years ago